Emergency Medicine and Medical Toxicology Physician-Scientist at @WeillCornell @ED_WCMC @WCMEmergency There is simply too much to think about
New York, NY
Joined February 2012
- Tweets2.7K
- Following54
- Followers180
- Likes1.9K
Michael Chary MD, PhD retweeted
Happy Monday! The latest episode of Tox in Ten ACMT Highlights is live! @gillianbchum sits down with @macacharya to discuss the role of artificial intelligence in medical toxicology
@acmtmedtox podcasts.apple.com/us/podcas…
Michael Chary MD, PhD retweeted
The best way to spend your Monday is listening to the newest @ToxInTen episode! @gillianbchum sits down with @macacharya to discuss the role of artificial intelligence in medical toxicology. #ToxTwitter #MedTwitter
Michael Chary MD, PhD retweeted
Dear friends of @eapcct
This week #toxreadingcorner is on “The Role and Promise of Artificial Intelligence in Medical Toxicology” by Michael A. Chary et al. link.springer.com/article/10… @macacharya @ManiniAlex @PEMTox
Michael Chary MD, PhD retweeted
Toxicology 2.0 symposium, now speaking: The geospatial and linguistic dynamics of conversations on Twitter about vaping. Michael Chary (2020 -Abstract 099) #EAPCCT2021 @macacharya
Michael Chary MD, PhD retweeted
.@macacharya @ToxInNewEngland: ‘A #transparentAI system may be useful by automating aspects [of] routine cases and in doing so freeing up expert time for more complicated cases’ of #overdose or #poisoning. #Toxicology #ExplainableAI ow.ly/413M50EVaZL
Michael Chary MD, PhD retweeted
Listening to my colleague Michael Chary MD PhD discuss AI in medical toxicology. #2021ACMT @acmtmedtox @WCMEmergency
Michael Chary MD, PhD retweeted
#2021ACMT Happening now: @macacharya shines a light on the role artificial intelligence can play in medical toxicology during his 2:30 PM talk. @WeillCornell
Michael Chary MD, PhD retweeted
Successful use of ECMO and lipid emulsion for massive bupropion overdose: a case report
doi.org/10.1080/24734306.202… from @MikeEMPharmD @macacharya @philmoonsamy et al @MassGeneralNews Well documented #bupropion poisoning treated with #ECMO and ILE.
Michael Chary MD, PhD retweeted
Exposure To Other Coronaviruses Does Not Give Immunity Against SARS-CoV-2
brief19.com/2021/02/12/brief via @Brief_19 @macacharya
Michael Chary MD, PhD retweeted
Here's the @Brief_19 Week in Review for COVID-19 research!
Take three minutes and catch up on the must know stories from the frontline this week.
Expertise from @angie_rasmussen @JPBelinkieMD @macacharya
brief19.com/2021/02/13/brief via @Brief_19
In @Brief_19 later this AM:
✔️Analysis on the new Moderna trial. One dose? Promising but by no means ready for prime time. With @macacharya
✔️Will vaccine hesitancy lead to vaccine mandates? Schools will be a major battleground. @JPBelinkieMD explains.
brief19.com/subscribe/
Our latest paper in Toxicology Communications: Early intravenous lipid emulsion therapy for diphenhydramine overdose: a case report.
tandfonline.com/doi/full/10.…
Latest articles in Toxicology Communications (2/2):
Early intravenous lipid emulsion therapy for diphenhydramine overdose: a case report.
tandfonline.com/doi/full/10.…
From Clemons et al of @KendallRMC and @macacharya of
@WeillCornell @ED_WCMC @WCMEmergency
Michael Chary MD, PhD retweeted
Back in June, @macacharya wrote a brief on a small trial of colchicine in Covid-19 for @Brief_19.
The results were promising.
New findings publicized via press release (COLCORONA trial) are far too vague to be useful.
But here's what we do know...
👇
brief19.com/2020/06/25/brief
Michael Chary MD, PhD retweeted
Daily briefings from @Brief_19 return tomorrow AM!
This week: frontline expertise on the latest in Covid-19 medical research from @bernardchangMD @sampx @macacharya and @JPBelinkieMD.
Written by docs *for everyone*
Subscribe free and get it first! 🙌
brief19.com/subscribe/
Michael Chary MD, PhD retweeted
BinaxNOW Antigen Testing Can Be Used In Asymptomatic Individuals. Is It Ready For Prime Time?
First, we must ask the right question...
brief19.com/2021/01/21/brief via @Brief_19 @macacharya
Michael Chary MD, PhD retweeted
Abbott's new rapid antigen test, BinaxNOW, has received EUA from the @US_FDA.
@macacharya on a new @CDCgov study evaluating use in asymptomatic individuals & what this means:
brief19.com/2021/01/21/brief…
ALT A picture of Abbott Laboratories’ BinaxNow kit. The kit is a dark blue box, with text that says "BinaxNOW COVID-19 Ag CARD" on the side. In front of the box, there is a small white plastic bottle, a folded open white antigen card, and a closed antigen card.
<Breaking>
Moderna vaccine trial has been published.
Our immediate analysis here, with updates in our AM briefing.
brief19.com/2020/12/30/moder… via @Brief_19 @macacharya
ALT Figure in New England journal of medicine NEJM.org
Check out our #HICSS54 paper discussing Probabilistic Logic Networks to diagnose acute poisonings, nominated for Best Paper! hdl.handle.net/10125/71050
#AI @ED_WCMC @WeillCornell @WCMEmergency
Can #AI help you ID that toxidrome? The first paper in our mini-track from #HICSS54 by @macacharya @ToxInNewEngland and @PEMTox discusses the use of Probabilistic Logic Networks to assist the diagnosis of acute poisonings
hdl.handle.net/10125/71050
Michael Chary MD, PhD retweeted
📍The Real Lessons From Sweden: Don’t Combine Covid-19 And Crowded Conditions.
Excess Mortality Can Be Lowered.
brief19.com/2020/10/28/brief via @Brief_19 @macacharya
Michael Chary MD, PhD retweeted
#FF.
@Brief_19 and the frontline docs who write it everyday!
@reverendofdoubt @joshualeskomd @LWestafer @sampx @fredmilgrim @macacharya @ActuallyDrJ @OnyekaOtugo @bernardchangMD and more...
And subscribe to the daily email for free: brief19.com/subscribe/.